By www.reliablemarketforecast.com
Global And United States Gene Therapy For CNS Disorders Market Report & Forecast 2023-2028 Story
93
$ 4350
Gene Therapy For CNS Disorders Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Gilead (Kite Pharma)
Amgen (BioVex)
Novartis
Roche (Spark Therapeutics)
Bluebird Bio